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Abstract Replacement by alanine of Ser-948, Thr-974 and Lys-
954 of Escherichia coli carbamoyl phosphate synthetase (CPS)
shows that these residues are involved in binding the allosteric
inhibitor UMP and the activator IMP. The mutant CPSs are
active in vivo and in vitro and exhibit normal activation by
ornithine, but the modulation by both UMP and IMP is either
lost or diminished. The results demonstrate that the sites for
UMP and IMP overlap and that the activator ornithine binds
elsewhere. Since the mutated residues were found in the crystal
structure of CPS near a bound phosphate, Ser-948, Thr-974 and
Lys-954 bind the phosphate moiety of UMP and IMP.
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1. Introduction
Carbamoyl phosphate synthetase (CPS) catalyzes the ¢rst
committed step in the routes of biosynthesis of pyrimidines,
arginine and urea [2ATP+HCO33 +NH3 (glutamine)
C2ADP+carbamoyl phosphate+Pi (+glutamate)], and is in
many cases regulated allosterically [1,2]. The e¡ectors vary
with the source and the physiological function of the CPS.
CPS I is involved in the synthesis of urea and is activated
by N-acetyl-L-glutamate, whereas the Escherichia coli enzyme,
which is involved in the synthesis of arginine and of pyrimi-
dines, is activated by ornithine and IMP and is inhibited by
UMP, and CPS II, which participates in the synthesis of pyr-
imidines in animals, is activated by phosphoribosyl pyrophos-
phate and is inhibited by UTP.
The structural bases of the allosteric modulation of CPS are
currently being elucidated. Di¡erent CPSs exhibit a similar
structural plan [3,4], epitomized by the E. coli enzyme. This
enzyme is composed of a small subunit of 41.4 kDa, which
binds and cleaves glutamine, and a large subunit of 117.7
kDa, which synthesizes carbamoyl phosphate from NH3 and
binds the e¡ectors [2] in its C-terminal domain of approxi-
mately 20 kDa [4]. We carried out photoa⁄nity labeling ex-
periments with the inhibitor UMP and the activator IMP that
revealed the cross-linking of these e¡ectors to Lys-993 [5] and
His-995 [6], respectively, two amino acid residues that are
found approximately at the middle of the amino acid sequence
of this domain. Based on the photoa⁄nity labeling by UMP
and IMP at these residues and on the e¡ects of replacing His-
995 by alanine on the binding of the two nucleotide e¡ectors
[6], we con¢rmed that these e¡ectors bind at overlapping sites,
and we proposed the involvement of speci¢c sequence regions
around Lys-993 in the formation of the binding site for the
nucleotide e¡ectors [5,6]. Recently the three-dimensional
structure of E. coli CPS was determined and a Pi ion was
localized binding to the crystal in the region assigned by us
to the e¡ector nucleotide site [7]. We have used the position of
this Pi and the sites of photoa⁄nity labeling by UMP and
IMP to model the bound e¡ector nucleotides [6] (Fig. 1).
We now subject to experimental testing this model by replac-
ing by alanine three key polar residues that interact with the
Pi. If such Pi truly represents the phosphate group of the
nucleotide e¡ectors, the negative e¡ect expected to be caused
on the binding of the Pi by the replacement of the polar
groups of these residues by the apolar and smaller side chain
of alanine should selectively hamper the modulation by UMP
and IMP. The results reported here con¢rm the importance of
these residues in the binding of the nucleotide e¡ectors.
2. Materials and methods
2.1. Site-directed mutagenesis and expression of mutant enzymes
Standard protocols were used for transformation of E. coli and for
isolation, digestion and ligation of DNA [8]. Plasmid DNA from
pLLK12 [9] (which contains the carAB gene inserted in the BamHI
site of pUC19; carA and carB encode the small and large CPS sub-
units) was digested with SmaI, and the DNA fragment (897 bp) en-
coding the C-terminal region of carB was isolated electrophoretically
and was ligated with the SmaI site of bacteriophage M13mp19. Site-
directed mutagenesis was carried out [10], using uracil-containing sin-
gle-stranded DNA generated in E. coli strain CJ236 [10] and the
antisense oligonucleotides 5P-GCCTTCGCGTACGGCAAGCAGC-
G-3P, 5P-CGTTCGGCGTCGCCTTCG-3P and 5P-GCCGTGCCATG-
GGCCGCATCCAGC-3P, in which the original triplets GGA, TTT
and GGT (complementary to the TCC, AAA and ACC codons en-
coding Ser-948, Lys-954 and Thr-974 of carB, respectively) are re-
placed by the underlined triplet (complementary to the GCC codon
for alanine). The mutations were corroborated by manual sequencing
[11] of single-stranded DNA isolated from individual colonies of
DH5K cells (from Clontech) transformed with the M13 vector con-
taining the mutated insert.
The mutant carAB genes were constructed by replacement of the
wild-type SmaI fragment of carB with the corresponding mutant frag-
ment carrying the desired mutation. The resultant plasmids
pLLK12S948A, pLLK12K954A and pLLK12T974A were sequenced
again to con¢rm the presence of the mutation and the correctness of
the construction, and were used to transform E. coli strain L814
(carAB3) [9]. The mutant CPSs were expressed in E. coli L814 strain
and grown overnight in LB medium. After spinning down the cells
and resuspension of the precipitate in 6 ml/g cell paste of K-phosphate
bu¡er 0.12 M, pH 7.6 containing 1 mM EDTA, the cell suspensions
were sonicated and centrifuged at 4‡C and the supernatant was used
for protein [12] and enzyme activity assays, SDS-PAGE [13], blotting
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and immunophosphatase staining [14] using a monoclonal mouse
IgG1 (MabCPSEc1) raised [14] against wild-type E. coli CPS.
2.2. Enzyme activity assays
Samples of the supernatants were desalted by centrifugal gel ¢ltra-
tion [15] through Sephadex G-50 equilibrated with the assay bu¡er.
CPS activity was determined by measuring as hydroxyurea at 450 nm
[16] the carbamoyl phosphate formed during 10 min incubation at
37‡C in a solution of 0.1 M Tris-HCl, pH 8, 0.1 M KCl, 10 mM
glutamine, equimolar ATP and MgCl2 (5 or 10 mM), 20 mM
NaHCO3 and the indicated concentration of either ornithine, UMP
or IMP. When testing the activation by ornithine, the assay solution
was supplemented with 25 U/ml ornithine transcarbamylase (from
Sigma) and the citrulline formed was determined identically to the
hydroxyurea at 450 nm. Controls made by adding carbamoyl phos-
phate to the solutions con¢rmed [16] that the color yield is the same
with hydroxylamine conversion to hydroxyurea and with ornithine
transcarbamylase conversion to citrulline.
3. Results
E. coli strain L814 has no CPS activity [9] and cannot grow
in minimal medium [17] unless uracil and arginine are added
(proline and thiamine are also needed by L814 cells, and are
added when using minimal medium, in amounts of 0.1 mg/ml
and 1 Wg/ml, respectively). L814 cells transformed with plas-
mid pLLK12, which carries the wild-type carAB genes, regain
the ability to grow in minimal medium. L814 cells trans-
formed with plasmids pLLK12S948A, pLLK12K954A or
pLLK12T974A, which carry the carAB genes with the carB
mutations Ser-948-Ala, Lys-954-Ala or Thr-974-Ala respec-
tively, also grew similarly in minimal medium. Therefore,
the mutant enzymes are expressed and are functional in
vivo. The amount of CPS produced, estimated densitometri-
cally from SDS-PAGE of extracts of the transformed cells,
stained with Coomassie or immunostained in Western blots
(Fig. 2), represented 16.5% of the protein in the extract for
wild-type CPS and 8.8%, 6% and 13% for the CPSs with the
mutations Ser-948-Ala, Lys-954-Ala and Thr-974-Ala, respec-
tively. Enzyme activity (assayed by coupling with ornithine
transcarbamylase as indicated in Section 2, in the presence
of 10 mM ATP, 20 mM MgCl2 and 4 mM ornithine) was,
in Wmol/min/mg protein in the extract, 0.79, 0.13, 0.07 and 1.9
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Fig. 1. Ribbon representation of the putative nucleotide e¡ector
binding site of E. coli CPS, with IMP shown in ball and stick repre-
sentation. The side chains of Ser-948, Lys-954 and Thr-974 are
shown explicitly in ball and stick representation. Broken sticks rep-
resent hydrogen bonds with the phosphate group of IMP (shown in
a darker shade of gray). The model was built using program O and
the coordinates deposited for carbamoyl phosphate synthetase (PDB
1JDB) [7]. IMP structure was taken from the library of heterocom-
pounds of Uppsala University (http://alpha2.bmc.uu.se/hicup/). The
nucleotide was positioned manually with the purine ring properly
positioned to account for the photoa⁄nity labeling of His-995 [6]
and with the phosphate at the position of the phosphate ion present
in the reported enzyme structure [7], keeping all atoms of the nu-
cleotide at a distance of at least 2 Aî from any atom of the protein,
to avoid potential steric problems.
Fig. 2. SDS-PAGE analysis (9% polyacrylamide) of the expression
of CPS (either wild-type, WT, or mutant, represented by the one-
letter convention for amino acid substitutions) in the bacterial cell
extracts used in the present studies. L814 denotes extracts of the
bacterial cells used for transformation. CPS denotes the puri¢ed
wild-type E. coli CPS. The double-pointed and single-pointed arrows
signal the large and small CPS subunits. Left panel: Immunoblot
analysis using as primary antibody MabCPSEc1 (0.01 mg/ml) and
alkaline phosphatase immunostaining with a conjugate (from Prom-
ega) of rabbit anti-mouse IgG. Right panel: Coomassie staining.
CPS was quantitated densitometrically by comparison with immuno-
blots and Coomassie-stained gels of appropriate amounts of puri¢ed
E. coli CPS, using for immunoblots a computer scanner and the
analysis program Sigmagel (from Sigma), and for gels an LKB Ul-
troscan densitometer.
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for the extracts of cells expressing wild-type, Ser-948-Ala, Lys-
954-Ala and Thr-974-Ala CPS forms, respectively. Using the
densitometric estimates of CPS content in the corresponding
extracts, the estimated speci¢c activity of the pure enzyme is
4.76 Wmol/min/mg for wild-type CPS and 1.45, 1.20 and 1.46
Wmol/min/mg for the Ser-948-Ala, Lys-954-Ala and Thr-974-
Ala mutant forms, respectively. The speci¢c activity estimated
for the wild-type enzyme is within the expected range for pure
E. coli CPS [18,19]. The lower estimated speci¢c activity of the
mutant forms of CPS does not re£ect substantial di¡erences in
enzyme solubility, since the mutant forms, similarly to wild-
type CPS, appeared mainly in the supernatant after centrifu-
gation of the sonicates of the transformed cells.
Fig. 3 shows that the Ser-948-Ala and Thr-974-Ala muta-
tions abolish the ability of the enzyme to be activated or
inhibited by IMP or UMP, respectively. The CPS with the
Lys-954-Ala mutation is still activated by IMP and inhibited
by UMP, but the degree of activation or inhibition attained is
considerably smaller than for the wild-type enzyme, and the
concentrations of UMP needed for inhibition are approxi-
mately two orders of magnitude higher than for wild-type
(Ki for UMPw5 WM for wild-type CPS [6]). In contrast
with the detrimental e¡ects of these mutations on the modu-
lation by the nucleotide e¡ectors, the mutants are activated by
ornithine similarly to wild-type CPS (Fig. 3).
4. Discussion
The large CPS subunit has been long known [18] to host the
sites for the e¡ectors. The sites for UMP and IMP have been
localized more recently [19,20] in the C-terminal 20 kDa do-
main, which is known as the regulatory or allosteric domain
because it is involved in the di¡erent CPSs in the regulatory
processes triggered by the various e¡ectors of these enzymes
[21]. The fact that the three residues mutated here are found
in this domain and that the mutations abolish or hamper the
modulation of the enzyme by UMP and IMP provides addi-
tional proof for the localization of the sites for these nucleo-
tide e¡ectors in this domain. Boettcher and Meister [22,23]
proposed on the basis of experiments with analogs of UMP
and IMP that these two e¡ectors bind at overlapping sites.
Con¢rmation of this view is provided by the present results
and by our recent ¢ndings that UMP and IMP are cross-
linked by UV light to Lys-993 [5] and His-995 [6] and that
the mutation His-995-Ala [6] selectively a¡ects the modulation
by both nucleotide e¡ectors. However, the present e¡ects are
much more dramatic than those triggered by the His-995-Ala
mutation, which only decreased the apparent a⁄nity for the
nucleotide e¡ectors by less than one order of magnitude,
whereas even in the less deleterious of the present mutations,
Lys-954-Ala, the apparent a⁄nity for UMP is decreased not
less than two orders of magnitude. In agreement with our
¢ndings, the enzyme with the mutation Ser-948-Phe was re-
ported [24] to be insensitive to purine and pyrimidine nucleo-
tides. Thus, the present results constitute conclusive proof that
UMP and IMP share the same site on the enzyme. In addi-
tion, given the lack of e¡ect of the present mutations on the
activation by ornithine, our results agree with the binding in
di¡erent sites of ornithine and of the nucleotide e¡ectors. This
solves doubts on the localization of the site for ornithine that
were raised by the report of ornithine binding at two sites in
the crystal structure of the enzyme, one in the neighborhood
of the phosphate, within the putative e¡ector nucleotide site,
and the other at the fringe between the C-terminal domain
and the remainder of the large subunit [7]. The present results
agree with the latter localization of the site for ornithine, an
activator that was previously shown to bind to the enzyme
with an stoichiometry of only an ornithine molecule per en-
zyme molecule [25].
Another question solved by the present studies is the dem-
onstration that the Pi found in CPS crystals occupies the site
for the phosphate group of the e¡ectors UMP and IMP. Pi
itself was also reported (see [2]) to be an e¡ector of E. coli
CPS, having a role in the ‘¢ne tuning’ of the allosteric regu-
lation of the enzyme. Interference of the present mutations
with the binding of such e¡ector Pi would be expected to
cause only modest changes in the responses of the enzyme
to the nucleotide e¡ectors rather than the dramatic changes
observed here. Thus, in agreement with the model shown in
Fig. 1, the three residues that have been mutated here appear
to participate in the site for the e¡ector nucleotide and, more
precisely, of the subsite for the nucleotide phosphate. The fact
that the mutations Ser-948-Ala and Thr-974-Ala abolish and
the mutation Lys-954-Ala has a partial e¡ect on both activa-
tion by IMP and inhibition by UMP suggests that in enzyme-
bound UMP and IMP the position of the phosphate group,
relative to the enzyme, is identical. Therefore, the di¡erent
modulatory e¡ects exerted by UMP and IMP are due to dif-
ferences in the binding to the same site of other parts of the
e¡ector molecule that deserve further investigation.
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Fig. 3. In£uence of IMP, UMP and ornithine on enzyme activity of
wild-type (WT) or mutant CPS. The mutations are indicated in sin-
gle-letter notation. ATPMg concentration was 10 mM in the inhibi-
tion assays with UMP and 5 mM in the activation assays with IMP
and ornithine. Ornithine was used at a concentration of 1.5 mM.
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